ANTI-RESTENOSIS DRUG COVERED AND ELUTING BALLOONS FOR VALVULOPLASTY OF AORTIC VALVE STENOSIS FOR THE PREVENTION OF RESTENOSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110098737A1
SERIAL NO

12920278

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are special balloons intended for use in valvuloplasty of stenosed aortic valves, with a potential use for valvuloplasty of other heart valves as well. A feature of these balloons is that the entire or part of their external surface is covered by a drug that is eluted at the valve tissues during the balloon brief contact with them at the time of dilatation. The drug acts against the process of restenosis, which almost uniformly occurs after some time. The shape of the balloon can be the classical cylindrical or an hour-glass shape that facilitates targeted delivery of the drug at the valve tissues.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EUROCOR GMBHRHEINWERKALLE 2 BONN 53227

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Spargias, Konstantinos Smimi Attikis, GR 5 86

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation